Goldman Sachs Group Inc Johnson & Johnson Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Goldman Sachs Group Inc holds 13,384,923 shares of JNJ stock, worth $2.05 Billion. This represents 0.36% of its overall portfolio holdings.

Number of Shares

13,384,923

Previous 10,618,072 26.06%

Holding current value

$2.05 Billion

Previous $1.55 Billion 39.77%

% of portfolio

0.36%

Previous 0.27%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $403 Million - $463 Million	2,766,851 Added 26.06%	13,384,923 $2.17 Billion
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $37.7 Million - $41.2 Million	261,389 Added 2.52%	10,618,072 $1.55 Billion
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $436 Million - $457 Million	-2,809,981 Reduced 21.34%	10,356,683 $1.64 Billion
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $73.5 Million - $80.2 Million	504,835 Added 3.99%	13,166,664 $2.06 Billion
Q3 2023 May 14, 2024	SELL	$155.75 - $174.48 $78.6 Million - $88.1 Million	-504,835 Reduced 3.83%	12,661,829 $1.97 Billion
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $372 Million - $417 Million	2,387,591 Added 23.24%	12,661,829 $1.97 Billion
Q2 2023 May 14, 2024	SELL	$154.35 - $166.11 $190 Million - $205 Million	-1,232,525 Reduced 10.71%	10,274,238 $1.7 Billion
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $190 Million - $205 Million	-1,232,525 Reduced 10.71%	10,274,238 $1.7 Billion
Q1 2023 May 14, 2024	SELL	$151.05 - $180.26 $160 Million - $191 Million	-1,061,987 Reduced 8.45%	11,506,763 $1.78 Billion
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $160 Million - $191 Million	-1,061,987 Reduced 8.45%	11,506,763 $1.78 Billion
Q4 2022 May 14, 2024	BUY	$160.2 - $179.79 $96.2 Million - $108 Million	600,752 Added 5.02%	12,568,750 $2.22 Billion
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $96.2 Million - $108 Million	600,752 Added 5.02%	12,568,750 $2.22 Billion
Q3 2022 May 14, 2024	BUY	$161.33 - $179.52 $6.01 Million - $6.69 Million	37,263 Added 0.31%	11,967,998 $1.96 Billion
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $6.01 Million - $6.69 Million	37,263 Added 0.31%	11,967,998 $1.96 Billion
Q2 2022 May 14, 2024	SELL	$168.19 - $186.01 $208 Million - $230 Million	-1,235,929 Reduced 9.39%	11,930,735 $2.12 Billion
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $49.5 Million - $54.8 Million	294,385 Added 2.53%	11,930,735 $2.12 Billion
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $19 Million - $21.6 Million	120,234 Added 1.04%	11,636,350 $2.06 Billion
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $290 Million - $321 Million	-1,857,539 Reduced 13.89%	11,516,116 $1.97 Billion
Q3 2021 Nov 10, 2021	BUY	$161.5 - $179.47 $2.16 Billion - $2.4 Billion	13,373,655 New	13,373,655 $2.16 Billion

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Johnson & Johnson Transaction History